Provided by Tiger Fintech (Singapore) Pte. Ltd.

Entero Therapeutics, Inc.

0.5499
+0.01693.17%
Post-market: 0.5301-0.0198-3.60%17:42 EDT
Volume:79.64K
Turnover:41.74K
Market Cap:2.61M
PE:-0.13
High:0.5579
Open:0.5200
Low:0.4912
Close:0.5330
Loading ...

Vicarious Surgical Names Sarah Romano Finance Chief

MT Newswires Live
·
13 Mar

Entero Therapeutics Names Richard Paolone Interim CEO

MT Newswires Live
·
15 Feb

Entero Therapeutics names Richard Paolone as interim CEO

TIPRANKS
·
15 Feb

Entero Therapeutics Appoints Richard Paolone as CEO

THOMSON REUTERS
·
15 Feb

Entero Therapeutics Gets $2 Million Revolving Loan, Appoints 3 New Board Members

MT Newswires Live
·
08 Feb

Entero Therapeutics secures $2M revolving loan, appoints three new directors

TIPRANKS
·
08 Feb

Entero Therapeutics Secures $2 Million Revolving Loan; Appoints Three New Board Members

THOMSON REUTERS
·
08 Feb

BRIEF-Entero Therapeutics Says Immunogenx Received Notice Of Default, Demand For Payment Relating To Credit Agreement

Reuters
·
28 Nov 2024

Entero Therapeutics Inc: Exploring Strategic Alternatives for Purpose of Maximizing Value of All of Our Stakeholders

THOMSON REUTERS
·
28 Nov 2024

Entero Therapeutics Inc: Expect to Continue to, Explore Various Potential Strategies Available to Co

THOMSON REUTERS
·
28 Nov 2024

Entero Therapeutics Inc: Acceleration or Reduction of Cash Outflows and Debt Obligations Can Significantly Impact Our Ability to Maintain Operations

THOMSON REUTERS
·
28 Nov 2024

Entero Therapeutics : Notice Informed Immunogenx That One or More Events of Default Under Credit Agreement Were Existing and Continuing

THOMSON REUTERS
·
28 Nov 2024

Entero Therapeutics Inc: Have Reduced Headcount and Paused Development Activities

THOMSON REUTERS
·
28 Nov 2024

Entero Therapeutics CEO James Sapirstein to Moderate the 2024 BioFlorida Annual Innovation Conference CEO Forum

GlobeNewswire
·
14 Nov 2024

Entero Therapeutics Inc expected to post a loss of 41 cents a share - Earnings Preview

Reuters
·
14 Nov 2024

BRIEF-Entero Therapeutics Announces Proposed Reverse Merger With Journey Therapeutics

Reuters
·
13 Nov 2024